6 Recruiting Advanced Solid Tumor Clinical Trials in Connecticut
Explore active advanced solid tumor research studies enrolling across Connecticut. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Advanced Solid Tumor Studies in Connecticut
🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Study of YL242 in Subjects With Advanced Solid Tumors
📍 US-201 — New Haven, Connecticut
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
SNV1521 in Participants With Advanced Solid Tumors
📍 Smilow Cancer Hospital at Yale New Haven — New Haven, Connecticut
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors
📍 Yale Cancer Center — New Haven, Connecticut
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
📍 Yale New Haven Hospital — New Haven, Connecticut
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Study of AVZO-021 in Patients With Advanced Solid Tumors
📍 Yale Cancer Center — New Haven, Connecticut
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Study of SGR-3515 In Participants With Advanced Solid Tumors.
📍 Yale University, Yale Cancer Center — New Haven, Connecticut
View Study & Checklist ➔